Matinas BioPharma Inc.
MTNB | AMEX
$1.08
-$0.43 (-28.48%)
Nov 2, 2026, 11:24 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.1M | 1.06M | 1.06M | 1.06M | n/a | -333 | n/a | n/a | 33.33K |
Cost of Revenue | 4K | 74K | -85K | 114K | 124K | 85K | 2.38M | 2.24M | 3.37M | 240K | 3.67M | 3.3M | 3.56M | 3.97M | 3.87M | 3.71M | 4.13M | 4.98M | 4.24M | 4.62M | 2.48M | 3.24M |
Gross Profit | -4K | -74K | 85K | -114K | -124K | -85K | -2.38M | -2.24M | -3.37M | -240K | -3.67M | -3.3M | -3.56M | -2.87M | -2.8M | -2.64M | -3.06M | -4.98M | -4.24M | -4.62M | -2.48M | -3.21M |
Operating Income | -1.56M | -1.94M | -1.6M | -1.58M | -1.84M | -1.95M | -8.47M | -4.38M | -5.84M | -5.9M | -5.89M | -6.13M | -6.16M | -5.59M | -5.48M | -5.46M | -5.93M | -7.72M | -6.71M | -6.88M | -4.79M | -6.35M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.33M | -1.92M | -1.91M | -2.15M | -5.25M | -1.66M | -8.51M | -4.28M | -5.72M | -5.82M | -5.31M | -6.06M | -6.06M | -5.51M | -3.63M | -5.46M | -5.92M | -5.98M | -6.7M | -6.84M | -4.79M | -4.96M |
Net Income | -1.33M | -1.92M | -1.91M | -2.15M | -5.25M | -1.66M | -8.43M | -4.28M | -5.72M | -5.82M | -5.31M | -6.06M | -6.06M | -5.51M | -3.63M | -5.46M | -5.92M | -5.98M | -6.7M | -6.84M | -4.79M | -4.96M |
Selling & General & Admin | 1.56M | 1.94M | 1.6M | 1.46M | 1.71M | 1.86M | 1.66M | 2.14M | 2.47M | 2.22M | 2.22M | 2.84M | 2.6M | 2.71M | 2.68M | 2.82M | 2.86M | 2.74M | 2.47M | 2.26M | 2.31M | 3.15M |
Research & Development | n/a | n/a | n/a | n/a | n/a | 85K | 2.38M | 2.24M | 3.37M | 3.45M | 3.67M | 3.3M | 3.56M | 3.97M | 3.87M | 3.71M | 4.13M | 4.98M | 4.24M | 4.62M | 2.48M | 3.24M |
Other Expenses | n/a | -74K | 85K | n/a | n/a | -85K | 2.06M | -2.24M | -3.37M | n/a | -3.67M | -3.3M | -3.56M | -3.97M | -3.87M | -3.71M | -4.13M | -4.98M | -4.24M | -4.62M | -2.48M | -3.24M |
Operating Expenses | 1.56M | 1.86M | 1.69M | 1.46M | 1.71M | 1.86M | 6.09M | 2.14M | 2.47M | 5.66M | 2.22M | 2.84M | 2.6M | 2.71M | 2.68M | 2.82M | 2.86M | 2.74M | 2.47M | 2.26M | 2.31M | 3.15M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -240K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.56M | 1.94M | 1.6M | 1.58M | 1.84M | 1.95M | 8.47M | 4.38M | 5.84M | 5.9M | 5.89M | 6.13M | 6.16M | 6.68M | 6.54M | 6.53M | 6.99M | 7.72M | 6.71M | 6.88M | 4.79M | 6.39M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -80K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 427.08K | 427.08K | 364.94K | 362.39K | 339.13K | 339.13K | 324.39K | 335.86K | 332.47K | 289.81K | 289.69K | 289.69K | 289.69K | 289.69K | 289.21K | 289.15K | 289.15K | 288.86K | 288.34K | 286.91K | 273.62K | 271.83K |
Shares Outstanding (Diluted) | 427.08K | 427.08K | 364.94K | 362.39K | 339.13K | 339.13K | 324.39K | 335.86K | 332.47K | 289.81K | 289.69K | 289.69K | 289.69K | 289.69K | 289.21K | 289.15K | 289.15K | 288.86K | 288.34K | 286.91K | 273.62K | 271.83K |
EPS (Basic) | -3.15 | -4.50 | -4.50 | -6 | -15.45 | -4.95 | -25.95 | -12.75 | -17.25 | -20.10 | -18.30 | -20.85 | -20.85 | -18.75 | -0.11 | -18.90 | -20.40 | -8.70 | -23.25 | -23.85 | -17.55 | -18.30 |
EPS (Diluted) | -3.15 | -4.50 | -4.50 | -6 | -15.45 | -4.95 | -25.95 | -12.75 | -17.25 | -20.10 | -18.30 | -20.85 | -20.85 | -18.75 | -0.11 | -18.90 | -20.40 | -8.70 | -23.25 | -23.85 | -17.55 | -18.30 |
EBITDA | -1.78M | -1.85M | -604K | -2.04M | -5.23M | -1.64M | -3.95M | -4.18M | -5.63M | -5.58M | -5.22M | -5.96M | -5.96M | -5.42M | -3.54M | -5.37M | -5.83M | -5.9M | -6.63M | -6.77M | -4.72M | -6.28M |
EBIT | -1.78M | -1.92M | -1.03M | -2.15M | -5.25M | -1.66M | -4.04M | -4.28M | -5.72M | -5.82M | -5.31M | -6.06M | -6.06M | -5.51M | -3.63M | -5.46M | -5.92M | -5.98M | -6.7M | -6.84M | -4.79M | -6.35M |
Depreciation & Amortization | 4K | 74K | 423K | 111K | 13K | 19K | 91K | 92K | 92K | 240K | 98K | 100K | 98K | 97K | 97K | 92K | 92K | 75K | 71.28K | 70.86K | 67.2K | 70.66K |
Add to Watchlist
Select watchlists to add or remove MTNB